Hot Stocks: Cidara Therapeutics, Inc. (NASDAQ:CDTX), Potash Corporation of Saskatchewan Inc. (NYSE:POT), Bristol-Myers Squibb Company (NYSE:BMY), Rite Aid (NYSE:RAD), Inovio Pharmaceuticals (NASDAQ:INO)

Cidara Therapeutics, Inc. (NASDAQ:CDTX) belongs to Healthcare sector. Its weekly performance is -4.94%. On last trading day company shares ended up $14.44. Cidara Therapeutics, Inc. (NASDAQ:CDTX) distance from 50-day simple moving average (SMA50) is -5.86%. Zacks downgraded shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX) from a hold rating to a sell rating in a research note released on Friday morning.

Potash Corporation of Saskatchewan Inc. (NYSE:POT) shares increased 0.35% in last trading session and ended the day at $28.89. POT Gross Margin is 38.70% and its return on assets is 8.90%. Potash Corporation of Saskatchewan Inc. (NYSE:POT) quarterly performance is -11.07%. Potash Corporation of Saskatchewan Inc. (NYSE:POT) announced that its Board of Directors has declared a quarterly dividend of US $0.38 per share payable July 31, 2015 to shareholders of record July 10, 2015.

On 13 July, Bristol-Myers Squibb Company (NYSE:BMY) shares increased 0.56% and was closed at $69.66. BMY EPS growth in last 5 year was -5.90%. Bristol-Myers Squibb Company (NYSE:BMY) year to date (YTD) performance is 19.35%. On 26 June, Bristol-Myers Squibb Company (NYSE:BMY) said that, it plans to close two sites, eliminate 100 positions and discontinue discovery-research efforts in virology while it makes adjustments for other expansions in research and development.

Rite Aid Corporation (NYSE:RAD) ended the last trading day at $8.89. Company weekly volatility is calculated as 3.66% and price to cash ratio as 4.69. Rite Aid Corporation (NYSE:RAD) showed a weekly performance of 7.24%. On 2 July, Rite Aid Corporation (NYSE:RAD) announced sales results for June. For the four weeks ended June 27, 2015, same store sales increased 2.4 percent over the prior-year period. June front-end same store sales increased 0.3 percent. Pharmacy same store sales, which included an approximate 226 basis points negative impact from new generic introductions, increased 3.4 percent.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares increased 1.88% in last trading session and ended the day at $7.60. INO return on assets is -27.30%. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) quarterly performance is -23.08%.Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that its Chief Executive Officer, Dr. J. Joseph Kim, has been selected by The Aspen Institute to join its Health Innovators Fellowship. Dr. Kim, who co-founded Inovio, will work with a group of 20 healthcare leaders challenged to generate new solutions to improve healthcare treatments, access and delivery.

Leave a Reply

Your email address will not be published. Required fields are marked *